159 related articles for article (PubMed ID: 21243774)
21. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
[TBL] [Abstract][Full Text] [Related]
22. "Second generation" of TSAO compounds directed against HIV-1 TSAO-resistant strains.
Lobatón E; Velázquez S; Pérez-Pérez MJ; Jimeno ML; San-Félix A; De Clercq E; Balzarini J; Camarasa MJ
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):707-10. PubMed ID: 11563097
[TBL] [Abstract][Full Text] [Related]
23. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication.
Naeger LK; Margot NA; Miller MD
Antivir Ther; 2001 Jun; 6(2):115-26. PubMed ID: 11491416
[TBL] [Abstract][Full Text] [Related]
24. Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.
He Y; Chen F; Yu X; Wang Y; De Clercq E; Balzarini J; Pannecouque C
Bioorg Chem; 2004 Dec; 32(6):536-48. PubMed ID: 15530994
[TBL] [Abstract][Full Text] [Related]
25. [Study on anti-HIV drugs in Egyptian medicinal plants].
Sun XF; Wang W; Du GY; Lu WB
Zhongguo Zhong Yao Za Zhi; 2002 Sep; 27(9):649-53, 679. PubMed ID: 12866564
[No Abstract] [Full Text] [Related]
26. Anti-HIV activity of extracts from Calendula officinalis flowers.
Kalvatchev Z; Walder R; Garzaro D
Biomed Pharmacother; 1997; 51(4):176-80. PubMed ID: 9207986
[TBL] [Abstract][Full Text] [Related]
27. New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors.
Cushman M; Casimiro-Garcia A; Hejchman E; Ruell JA; Huang M; Schaeffer CA; Williamson K; Rice WG; Buckheit RW
J Med Chem; 1998 Jun; 41(12):2076-89. PubMed ID: 9622549
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of four Cameroonian medicinal plants for anticancer, antigonorrheal and antireverse transcriptase activities.
Mbaveng AT; Kuete V; Mapunya BM; Beng VP; Nkengfack AE; Meyer JJ; Lall N
Environ Toxicol Pharmacol; 2011 Sep; 32(2):162-7. PubMed ID: 21843795
[TBL] [Abstract][Full Text] [Related]
29. [Anti-HIV-1 effect of compound K3 from flower of Japanese pagoda tree in vitro].
Zhang GH; Zheng YT
Zhong Yao Cai; 2006 Apr; 29(4):355-8. PubMed ID: 16913492
[TBL] [Abstract][Full Text] [Related]
30. Flavonol and chalcone ester glycosides from Bidens leucantha.
De Tommasi N; Pizza C; Aquino R; Cumandà J; Mahmood N
J Nat Prod; 1997 Mar; 60(3):270-3. PubMed ID: 9090869
[TBL] [Abstract][Full Text] [Related]
31. Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants.
Dykes C; Fox K; Lloyd A; Chiulli M; Morse E; Demeter LM
Virology; 2001 Jul; 285(2):193-203. PubMed ID: 11437654
[TBL] [Abstract][Full Text] [Related]
32. [Universal modular system for in vitro screening of potential inhibitors of HIV-1 replication].
Prokof'eva MM; Orlova NN; Gornostaeva AS; Shul'gin AA; Nikitenko NA; Senchenko VN; Lebedev TD; Spirin PV; Riechen K; Fehse B; Stocking C; Prasolov VS
Mol Biol (Mosk); 2014; 48(2):344-8. PubMed ID: 25850304
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 inhibitory compounds from Calophyllum brasiliense leaves.
Huerta-Reyes M; Basualdo Mdel C; Abe F; Jimenez-Estrada M; Soler C; Reyes-Chilpa R
Biol Pharm Bull; 2004 Sep; 27(9):1471-5. PubMed ID: 15340243
[TBL] [Abstract][Full Text] [Related]
34. Extract of Prunella vulgaris spikes inhibits HIV replication at reverse transcription in vitro and can be absorbed from intestine in vivo.
Kageyama S; Kurokawa M; Shiraki K
Antivir Chem Chemother; 2000 Mar; 11(2):157-64. PubMed ID: 10819439
[TBL] [Abstract][Full Text] [Related]
35. Purification and characterization of anti-HIV-1 protein from Canna indica L. leaves.
Thepouyporn A; Yoosook C; Chuakul W; Thirapanmethee K; Napaswad C; Wiwat C
Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1153-60. PubMed ID: 23431821
[TBL] [Abstract][Full Text] [Related]
36. Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo.
Notka F; Meier G; Wagner R
Antiviral Res; 2004 Nov; 64(2):93-102. PubMed ID: 15498604
[TBL] [Abstract][Full Text] [Related]
37. Anti-HIV activities of the compounds isolated from Polygonum cuspidatum and Polygonum multiflorum.
Lin HW; Sun MX; Wang YH; Yang LM; Yang YR; Huang N; Xuan LJ; Xu YM; Bai DL; Zheng YT; Xiao K
Planta Med; 2010 Jun; 76(9):889-92. PubMed ID: 20112182
[TBL] [Abstract][Full Text] [Related]
38. Anti-AIDS agents. Part 57: Actein, an anti-HIV principle from the rhizome of Cimicifuga racemosa (black cohosh), and the anti-HIV activity of related saponins.
Sakurai N; Wu JH; Sashida Y; Mimaki Y; Nikaido T; Koike K; Itokawa H; Lee KH
Bioorg Med Chem Lett; 2004 Mar; 14(5):1329-32. PubMed ID: 14980692
[TBL] [Abstract][Full Text] [Related]
39. Xanthohumol, a novel anti-HIV-1 agent purified from Hops Humulus lupulus.
Wang Q; Ding ZH; Liu JK; Zheng YT
Antiviral Res; 2004 Dec; 64(3):189-94. PubMed ID: 15550272
[TBL] [Abstract][Full Text] [Related]
40. Current insights into reverse transcriptase inhibitor-associated resistance.
Wainberg MA; White AJ
Antivir Ther; 2001; 6 Suppl 2():11-9. PubMed ID: 11678474
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
